4.00
price up icon4.17%   0.16
pre-market  Vorhandelsmarkt:  3.99   -0.010   -0.25%
loading

Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten

pulisher
Jan 21, 2026

Analysis Recap: Is Organogenesis Holdings Inc backed by strong institutional buyingJuly 2025 Final Week & Real-Time Stock Movement Alerts - baoquankhu1.vn

Jan 21, 2026
pulisher
Jan 20, 2026

Aug Macro: Is Organogenesis Holdings Inc a strong growth stockJuly 2025 Action & Accurate Intraday Trade Tips - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 17, 2026

About Us - FinancialContent

Jan 17, 2026
pulisher
Jan 17, 2026

The Market Doesn't Like What It Sees From Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Revenues Yet As Shares Tumble 28% - simplywall.st

Jan 17, 2026
pulisher
Jan 16, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - yourwyominglink.com

Jan 16, 2026
pulisher
Jan 15, 2026

Hedge Fund Bets: Is Organogenesis Holdings Inc benefiting from innovation trendsDay Trade & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 13, 2026

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent

Jan 13, 2026
pulisher
Jan 13, 2026

Europe Advanced Wound Care Market Size, Share Projections 2032 - openPR.com

Jan 13, 2026
pulisher
Jan 12, 2026

Published on: 2026-01-13 05:15:38 - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 11, 2026

Is Organogenesis Holdings (NASDAQ:ORGO) In A Good Position To Invest In Growth? - Sahm

Jan 11, 2026
pulisher
Jan 10, 2026

Organogenesis drops as Medicare to pull skin substitute LCDs (update) - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

Is Organogenesis Holdings Inc. (2PQ) stock protected from inflationJuly 2025 Action & Free Technical Pattern Based Buy Signals - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Is Organogenesis Holdings Inc. stock a buy in volatile markets2025 Top Decliners & Growth Oriented Trade Recommendations - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

What margin trends mean for Organogenesis Holdings Inc. stockIPO Watch & Pattern Based Trade Signal System - Улправда

Jan 08, 2026
pulisher
Jan 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis ... - Bluefield Daily Telegraph

Jan 06, 2026
pulisher
Jan 06, 2026

News - FinancialContent

Jan 06, 2026
pulisher
Jan 05, 2026

ORGOOrganogenesis Hldgs Inc Latest Stock News & Market Updates - Stock Titan

Jan 05, 2026
pulisher
Jan 05, 2026

Three rising investors just landed bigger roles at a healthcare PE firm - Stock Titan

Jan 05, 2026
pulisher
Jan 04, 2026

Organogenesis (NASDAQ:ORGO) Trading Down 5% – Time to Sell? - Defense World

Jan 04, 2026
pulisher
Jan 02, 2026

Organogenesis (NASDAQ:ORGO) Shares Down 5%Here's What Happened - MarketBeat

Jan 02, 2026
pulisher
Jan 02, 2026

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring 64% Potential Upside Amidst Strong Revenue Growth - DirectorsTalk Interviews

Jan 02, 2026
pulisher
Dec 29, 2025

Organogenesis Holdings extends leases for Canton facilities through 2032 By Investing.com - Investing.com Australia

Dec 29, 2025
pulisher
Dec 29, 2025

Organogenesis Holdings extends leases for Canton facilities through 2032 - Investing.com

Dec 29, 2025
pulisher
Dec 29, 2025

Organogenesis Extends Long-Term Leases for Key Facilities - TipRanks

Dec 29, 2025
pulisher
Dec 26, 2025

Organogenesis (NASDAQ:ORGO) Shares Gap DownTime to Sell? - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Organogenesis' (ORGO) "Buy" Rating Reiterated at BTIG Research - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Organogenesis stock holds Buy rating at BTIG after CMS LCD decision - Investing.com Australia

Dec 26, 2025
pulisher
Dec 26, 2025

Organogenesis stock holds Buy rating at BTIG after CMS LCD decision By Investing.com - Investing.com South Africa

Dec 26, 2025
pulisher
Dec 24, 2025

Organogenesis stock rises after initiating FDA application for knee arthritis treatment By Investing.com - Investing.com India

Dec 24, 2025
pulisher
Dec 24, 2025

Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq

Dec 24, 2025
pulisher
Dec 23, 2025

Organogenesis begins FDA rolling review for knee arthritis treatment By Investing.com - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha

Dec 23, 2025
pulisher
Dec 23, 2025

Organogenesis stock rises after initiating FDA application for knee arthritis treatment - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

Organogenesis begins FDA rolling review for knee arthritis treatment - Investing.com

Dec 23, 2025
pulisher
Dec 23, 2025

Organogenesis Announces Initiation of Biologics License Application for ReNu® - The Manila Times

Dec 23, 2025
pulisher
Dec 23, 2025

Organogenesis Holdings Inc. Initiates Biologics License Application for ReNu® to Address Knee Osteoarthritis Pain - Quiver Quantitative

Dec 23, 2025
pulisher
Dec 23, 2025

Biologic treatment for knee arthritis pain begins FDA license bid - Stock Titan

Dec 23, 2025
pulisher
Dec 23, 2025

Gains Recap: Is Organogenesis Holdings Inc stock dividend yield sustainableWeekly Gains Report & Fast Gaining Stock Strategy Reports - moha.gov.vn

Dec 23, 2025
pulisher
Dec 22, 2025

Net current asset value per share of Organogenesis Holdings, Inc. Class A – BER:2PQ - TradingView — Track All Markets

Dec 22, 2025
pulisher
Dec 21, 2025

BTIG reiterates Organogenesis Holdings (ORGO) buy recommendation - MSN

Dec 21, 2025
pulisher
Dec 21, 2025

Is Organogenesis Holdings Inc. stock a bargain at current levels2025 Momentum Check & Advanced Technical Analysis Signals - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO - MarketBeat

Dec 20, 2025
pulisher
Dec 19, 2025

Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling - MarketBeat

Dec 19, 2025
pulisher
Dec 19, 2025

Organogenesis Holdings Inc. (ORGO) Stock Analysis: 47% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews

Dec 19, 2025
drug_manufacturers_specialty_generic RDY
$13.71
price up icon 3.24%
$24.91
price up icon 2.51%
$137.37
price up icon 1.45%
drug_manufacturers_specialty_generic RGC
$30.77
price up icon 40.44%
$13.24
price up icon 1.46%
$472.06
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):